Campus Operating Status:

Rutgers University–Camden is open and operating. Rutgers faculty, staff, and students can schedule COVID-19 vaccine appointments at campus locations in Camden, Piscataway/New Brunswick, and Newark. Make an appointment.

Latest COVID-19 Info

Rutgers–Camden Finest

Rutgers–Camden Finest is an assembly of graduates whose lives and careers have made an indelible mark upon society and the advancement of knowledge.


Stephen A. Tullman
SBC’89
Co-Founder and Managing Partner, NeXeption, LLC

Stephen Tullman’s career spans more than 25 years of biopharmaceutical global commercialization and drug development experience. He serves as the co-founder and managing partner for NeXeption, LLC, and co-founder and chair of Aclaris Therapeutics.

He was chair and CEO of Ceptaris Therapeutics (acquired by Actelion in 2013); co-founder and chair of Vicept Therapeutics (acquired by Allergan in 2011); co-founder, president, and CEO of Ception Therapeutics (acquired by Cephalon in 2010); and co-founder of Trigenesis Therapeutics, a dermatology company (acquired by Reddy's Laboratories in 2004).

He also served on the Board of Directors for Euromed, a wound care company. Tullman started his career at SmithKline Beecham and held positions of increasing responsibility in finance, sales, marketing, and research and development.